Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Managing osteonecrosis of the jaw

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.17
Views: 926

Dr Robert Marx - University of Miami Hospital, Miami, USA

Dr Marx speaks with ecancer at NOSCM 2017 to discuss osteonecrosis of the jaw.

He outlines the cancer drugs linked to disease onset, and gives the perspective of facial/dental surgeons in minimising adverse events and promoting therapy adherence.

In terms of managing infection, Dr Marx recommends penicillin-based antibiotics or anthracyclines, and in the case of advanced disease he describes how surgical interventions can preserve appearance and quality of life.

Related videos

follow us

WIN 2018

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence